Starch binding domain-containing protein 1 plays a dominant role in glycogen transport to lysosomes in liver

Journal of Biological Chemistry

Volumn 291, Issue 32, 2016, Pages 16479-16484

  Sun, Tao ^a   Yi, Haiqing ^a   Yang, Chunyu ^a   Kishnani, Priya S ^a   Sun, Baodong ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCLE; STARCH;

ALPHA GLUCOSIDASE; CARDIAC MUSCLES; HYDROPHOBIC SEGMENT; KNOCKOUT MICE; N-TERMINALS; SKELETAL MUSCLE; STARCH BINDING DOMAIN; TRANSMEMBRANE REGIONS;

MAMMALS;

CELL PROTEIN; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLYCOGEN; STARCH BINDING DOMAIN CONTAINING PROTEIN 1; UNCLASSIFIED DRUG; GENX-3414 PROTEIN, HUMAN; MEMBRANE PROTEIN; MUSCLE PROTEIN; STARCH-BINDING DOMAIN-CONTAINING PROTEIN 1, MOUSE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BIOACCUMULATION; CARBOXY TERMINAL SEQUENCE; CARDIAC MUSCLE; CONTROLLED STUDY; GLYCOGEN ANALYSIS; GLYCOGEN LIVER LEVEL; GLYCOGEN MUSCLE LEVEL; HYDROPHOBICITY; LIVER LYSOSOME; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; SKELETAL MUSCLE; ACTIVE TRANSPORT; ANIMAL; GENETICS; HUMAN; KNOCKOUT MOUSE; LIVER; LYSOSOME; METABOLISM; PHYSIOLOGY;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; GLYCOGEN; HUMANS; LIVER; LYSOSOMES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOCARDIUM;

EID: 84982868447     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.C116.741397     Document Type: Article

References (27)

1. Geddes, R., and Stratton, G. C. (1977) The influence of lysosomes on glycogen metabolism. Biochem. J. 163, 193-200
2. Roach, P. J., Depaoli-Roach, A. A., Hurley, T. D., and Tagliabracci, V. S. (2012) Glycogen and its metabolism: some new developments and old themes. Biochem. J. 441, 763-787
3. Adeva-Andany, M. M., González-Lucán, M., Donapetry-García, C., Fernández-Fernández, C., and Ameneiros-Rodríguez, E. (2016) Glycogen metabolism in humans. BBA Clin. 5, 85-100
4. Kishnani, P. S., and Howell, R. R. (2004) Pompe disease in infants and children. J. Pediatr. 144, S35-43
5. Melvin, J. J. (2000) Pompe's disease. Arch. Neurol. 57, 134-135
6. Kishnani, P. S., Koeberl, D., and Chen, Y. T. (2009) Glycogen storage diseases. in The Online Metabolic & Molecular Bases of Inherited Disease (Valle, D., Beaudet, A., Vogelstein, B., Kinzler, K., Antonarakis, S., and Ballabio, A. eds.), Chapter 7, Glycogen Storage Diseases, McGraw-Hill, New York
7. Kishnani, P. S., Goldenberg, P. C., DeArmey, S. L., Heller, J., Benjamin, D., Young, S., Bali, D., Smith, S. A., Li, J. S., Mandel, H., Koeberl, D., Rosenberg, A., and Chen, Y. T. (2010) Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants. Mol. Genet. Metab. 99, 26-33
8. Amalfitano, A., Bengur, A. R., Morse, R. P., Majure, J. M., Case, L. E., Veerling, D. L., Mackey, J., Kishnani, P., Smith, W., McVie-Wylie, A., Sullivan, J. A., Hoganson, G. E., Phillips, J. A., 3rd, Schaefer, G. B., Charrow, J., et al. (2001) Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet. Med. 3, 132-138
9. de Vries, J. M., van der Beek, N. A., Kroos, M. A., Ozkan, L., van Doorn, P. A., Richards, S. M., Sung, C. C., Brugma, J. D., Zandbergen, A. A., van der Ploeg, A. T., and Reuser, A. J. (2010) High antibody titer in an adult with Pompe disease affects treatment with alglucosidase α. Mol. Genet. Metab. 101, 338-345
10. Chakrapani, A., Vellodi, A., Robinson, P., Jones, S., and Wraith, J. E. (2010) Treatment of infantile Pompe disease with alglucosidase α: the UK experience. J. Inherit. Metab. Dis. 33, 747-750
11. Patel, T. T., Banugaria, S. G., Case, L. E., Wenninger, S., Schoser, B., and Kishnani, P. S. (2012) The impact of antibodies in late-onset Pompe disease: a case series and literature review. Mol. Genet. Metab. 106, 301-309
12. Raben, N., Schreiner, C., Baum, R., Takikita, S., Xu, S., Xie, T., Myerowitz, R., Komatsu, M., Van der Meulen, J. H., Nagaraju, K., Ralston, E., and Plotz, P. H. (2010) Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder-murine Pompe disease. Autophagy 6, 1078-1089
13. Jiang, S., Heller, B., Tagliabracci, V. S., Zhai, L., Irimia, J. M., DePaoli-Roach, A. A., Wells, C. D., Skurat, A. V., and Roach, P. J. (2010) Starch binding domain-containing protein 1/genethonin 1 is a novel participant in glycogen metabolism. J. Biol. Chem. 285, 34960-34971
14. Jiang, S., Wells, C. D., and Roach, P. J. (2011) Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1. Biochem. Biophys. Res. Commun. 413, 420-425
15. Bouju, S., Lignon, M. F., Piétu, G., Le Cunff, M., Léger, J. J., Auffray, C., and Dechesne, C. A. (1998) Molecular cloning and functional expression of a novel human gene encoding two 41-43 kDa skeletal muscle internal membrane proteins. Biochem. J. 335, 549-556
16. Yi, H., Fredrickson, K. B., Das, S., Kishnani, P. S., and Sun, B. (2013) Stbd1 is highly elevated in skeletal muscle of Pompe disease mice but suppression of its expression does not affect lysosomal glycogen accumulation. Mol. Genet. Metab. 109, 312-314
17. Raben, N., Nagaraju, K., Lee, E., Kessler, P., Byrne, B., Lee, L., LaMarca, M., King, C., Ward, J., Sauer, B., and Plotz, P. (1998) Targeted disruption of the acid α-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J. Biol. Chem. 273, 19086-19092
18. Zhu, Y., Zhang, M., Kelly, A. R., and Cheng, A. (2014) The carbohydrate-binding domain of overexpressed STBD1 is important for its stability and protein-protein interactions. Biosci. Rep. 34, e00117
19. Le Grand, J. N., Chakrama, F. Z., Seguin-Py, S., Fraichard, A., Delage-Mourroux, R., Jouvenot, M., and Boyer-Guittaut, M. (2011) GABARAPL1 (GEC1): original or copycat? Autophagy 7, 1098-1107
20. Nemos, C., Mansuy, V., Vernier-Magnin, S., Fraichard, A., Jouvenot, M., and Delage-Mourroux, R. (2003) Expression of gec1/GABARAPL1 versus GABARAP mRNAs in human: predominance of gec1/GABARAPL1 in the central nervous system. Brain Res. Mol. Brain Res. 119, 216-219
21. Chakrama, F. Z., Seguin-Py, S., Le Grand, J. N., Fraichard, A., Delage-Mourroux, R., Despouy, G., Perez, V., Jouvenot, M., and Boyer-Guittaut, M. (2010) GABARAPL1 (GEC1) associates with autophagic vesicles. Autophagy 6, 495-505
22. Xu, F., Ding, E., Liao, S. X., Migone, F., Dai, J., Schneider, A., Serra, D., Chen, Y. T., and Amalfitano, A. (2004) Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model. Gene Ther. 11, 1590-1598
23. Kota, J., Chivukula, R. R., O'Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H. W., Chang, T. C., Vivekanandan, P., Torbenson, M., Clark, K. R., Mendell, J. R., and Mendell, J. T. (2009) Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017
24. Sun, B., Young, S. P., Li, P., Di, C., Brown, T., Salva, M. Z., Li, S., Bird, A., Yan, Z., Auten, R., Hauschka, S. D., and Koeberl, D. D. (2008) Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy. Mol. Ther. 16, 1366-1371
25. Hermens, W. T., ter Brake, O., Dijkhuizen, P. A., Sonnemans, M. A., Grimm, D., Kleinschmidt, J. A., and Verhaagen, J. (1999) Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum. Gene Ther. 10, 1885-1891
26. Lock, M., Alvira, M., Vandenberghe, L. H., Samanta, A., Toelen, J., Debyser, Z., and Wilson, J. M. (2010) Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum. Gene Ther. 21, 1259-1271
27. Yi, H., Thurberg, B. L., Curtis, S., Austin, S., Fyfe, J., Koeberl, D. D., Kishnani, P. S., and Sun, B. (2012) Characterization of a canine model of glycogen storage disease type IIIa. Dis. Model. Mech. 5, 804-811